Public health, innovation, intellectual property and trade

WHO, WIPO, WTO unveil study on promoting innovation and access to medicines and health technology

For the first time, the three intergovernmental organizations dealing with health, intellectual property and trade have pooled their expertise to produce a study of the mix of policies needed to advance medical technologies and to ensure they reach the people who need them the most. The study, “Promoting Access to Medical Technologies and Innovation“, was launched on 5 February 2013, by the heads of the three organizations — WHO, World Intellectual Property Organization (WIPO) and World Trade Organization (WTO). Former Swiss President Ruth Dreifuss, who is also the former Chairperson of the WHO Commission on Intellectual Property, Innovation and Public Health (CIPIH), chaired the event.

WHO publishes draft Working Papers on R&D financing and coordination

In order to deepen the analyses presented in the Background document prepared for the open-ended meeting of Member States in November 2012 - where the report and the feasibility of the recommendations proposed by the Consultative Expert Review Group's report were discussed - the WHO Secretariat has developed draft Working Papers focusing on four main elements: the Global Observatory for Health Research and Development (R&D); R&D coordination and prioritization; R&D financing; and options for demonstration projects. The Working Papers are drafts and will be revised based on feedback received.

Report on financing and coordination of research and development

The Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) was established by the World Health Assembly (WHA) in 2010. The CEWG submitted its final report to the 65th World Health Assembly. The report is now available in English, French, Spanish, Russian, Arabic and Chinese.

New publications on local production for access to medical products

The outputs of phase 1 of this project were published at a seminar in the European Parliament on 7 December 2011. The aim of this work was to develop a framework that could bring together and guide policymakers and others from all relevant fields to support the local production of medicines, vaccines and diagnostics in a manner that should improve access maximizing the potential to improve public health.

Contact us

Department of Public Health, Innovation and Intellectual Property
World Health Organization
Avenue Appia 20
1211 Geneva
Switzerland
phidepartment@who.int